Skip to main content

Ashe Gena L's Form 4/A amendment

Amended

Anterix Inc. (ATEX) · filed Sep 11, 2026

Accession no.
0001669943-26-000021
Filed
Sep 11, 2026, 4:08 PM ET
Trade date
Sep 8, 2026
Filing delay
3 days
Rule 10b5-1 plan
Not checked
Original filed
Sep 8, 2026

This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $372.3K. It was filed 3 days after the trade.

This amendment replaces 0001669943-26-000019 (filed Sep 8, 2026).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Ashe Gena LCIK 0001669943Officer (Chief Legal Officer & Corp Sec)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 8, 2026Common StockSSaleDisposed−293$85.44−$25,033.929,238Direct
Sep 8, 2026Common StockMOption exerciseAcquired+6,833$34.96+$238,881.6816,071Direct
Sep 8, 2026Common StockFTax withholdingDisposed−2,769$86.27−$238,881.6313,302Direct
Sep 8, 2026Common StockSSaleDisposed−4,064$85.44−$347,228.169,238Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 8, 2026Common StockMOption exerciseDisposed−6,833$0.00$035,658Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The Reporting Person exercised a stock option to purchase 6,833 shares of the Issuer's Common Stock for $34.96 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding an aggregate of 2,769 shares of the Issuer's Common Stock subject to the stock option to pay the exercise price and to satisfy its income tax withholding and remittance obligations in connection with the exercise of the stock option. The withholding of shares referenced here does not involve an open market sale of stock.

F2

The option shares subject to this option shall vest and become exercisable in three equal annual installments, with 1/3 of the option shares vesting and becoming exercisable on May 20, 2026, and with the remaining option shares vesting and becoming exercisable in 2 equal annual installments thereafter.

Read the full filing on SEC EDGAR (opens in a new tab)